Lindbrook Capital, LLC - MIRUM PHARMACEUTICALS INC ownership

MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 74 filers reported holding MIRUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,636
+53.6%
210
+25.7%
0.00%
Q2 2023$4,320
-55.5%
167
-58.7%
0.00%
-100.0%
Q1 2023$9,704
+110.0%
404
+70.5%
0.00%0.0%
Q4 2022$4,622
-84.1%
237
-84.2%
0.00%
-87.5%
Q3 2020$29,000
+190.0%
1,500
+200.0%
0.01%
+166.7%
Q2 2020$10,000
-79.6%
500
-75.0%
0.00%
-82.4%
Q4 2019$49,0002,0000.02%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 3,566,912$62,278,0004.80%
RiverVest Venture Management LLC 1,921,118$33,543,0003.68%
Burrage Capital Management LLC 161,628$2,822,0002.15%
AIGH Capital Management LLC 274,583$4,794,0001.95%
NEA Management Company, LLC 4,187,801$73,119,0001.93%
Novo Holdings A/S 2,445,147$42,692,0001.83%
Sio Capital Management, LLC 494,743$8,638,0001.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,448,912$60,218,0001.19%
Rock Springs Capital Management LP 1,496,525$26,129,0000.55%
Prosight Management, LP 60,250$1,052,0000.49%
View complete list of MIRUM PHARMACEUTICALS INC shareholders